Dual-eligible, dual-risk? A brief review on the impact of dual-eligible status on health disparities and peripheral artery disease.


Journal

Seminars in vascular surgery
ISSN: 1558-4518
Titre abrégé: Semin Vasc Surg
Pays: United States
ID NLM: 8809602

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 21 10 2022
revised: 19 12 2022
accepted: 24 12 2022
entrez: 23 3 2023
pubmed: 24 3 2023
medline: 28 3 2023
Statut: ppublish

Résumé

Peripheral artery disease (PAD) has been associated with poorer outcomes based on particular social determinants of health, including insurance status. A unique population to study treatment outcomes related to PAD is those with dual-eligible status-those who qualify for both Medicare and Medicaid-comprising more than 12 million people. We performed a systematic review of the literature surrounding dual-eligible patients and impact on PAD, with final inclusion of six articles. Dual eligibility has been associated with higher rates of comorbidities; more severe symptoms at initial presentation for PAD; and poorer treatment outcomes, including mortality. Further studies are needed to specifically look at the association between PAD and dual-eligible status, but what is clear is that patients in this population would benefit from early identification to prevent disease progression and improve equity.

Identifiants

pubmed: 36958899
pii: S0895-7967(22)00083-7
doi: 10.1053/j.semvascsurg.2022.12.005
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

64-68

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Dominique M Dockery (DM)

Warren Alpert Medical School of Brown University, Providence, RI; Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI.

Chibueze A Nwaiwu (CA)

Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI; Department of Surgery, Lifespan Health System and Warren Alpert Medical School of Brown University, Providence, RI.

Yao Liu (Y)

Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI; Department of Surgery, Lifespan Health System and Warren Alpert Medical School of Brown University, Providence, RI.

Adrienne Green (A)

Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI.

Aron H Licht (AH)

Warren Alpert Medical School of Brown University, Providence, RI.

Stanley Ewala (S)

Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI.

Dayann Leal (D)

Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI.

Carla C Moreira (CC)

Supporting Underrepresented Research to Generate Equity (SURGE) Laboratory, Warren Alpert Medical School of Brown University, Providence, RI; Department of Surgery, Lifespan Health System and Warren Alpert Medical School of Brown University, Providence, RI; Division of Vascular Surgery, Department of Surgery, Warren Alpert Medical School of Brown University, 2 Dudley Street, Suite 470, Providence, RI 02905. Electronic address: Carla_Moreira@Brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH